Market Overview

UPDATE: Morgan Stanley Raises PT on Agilent on Multi-Year Margin Improvement Story

Share:
Related A
Goldman's 7 Favorite Biotech Ideas For 2016
Goldman Bullish On Agilent Technologies, Raises Price Target To $53

In a report published Friday, Morgan Stanley analyst Daniel Brennan reiterated an Overweight rating on Agilent Technologies (NYSE: A), and raised the price target from $49.00 to $60.00.

In the report, Morgan Stanley noted, “We like Agilent's multi-year margin improvement story, organic growth profile and superior ROIC profile – all of which have been overshadowed by the macro weakness. The decision to break the company into two pieces is an important value-creating event, allowing the appropriate investor bases to analyze/evaluate each piece (leading to multiple expansion), enabling separate mgmt teams to form distinct strategies and allocate capital appropriately, and affording upside optionality given sector consolidation.”

Agilent Technologies closed on Thursday at $50.98.

Latest Ratings for A

DateFirmActionFromTo
Aug 2016BairdMaintainsOutperform
Aug 2016BTIG ResearchMaintainsBuy
Aug 2016Cowen & CompanyMaintainsOutperform

View More Analyst Ratings for A
View the Latest Analyst Ratings

Posted-In: Daniel Brennan Morgan StanleyAnalyst Color Price Target Analyst Ratings

 

Related Articles (A)

View Comments and Join the Discussion!